Lilly has sought priority FDA review of its oral drug, called orforglipron
CHALLENGES TO DEVELOPMENT In developing the second-generation amylin-analog cagrilintide there were 2 main barriers: (1) to prevent amylin protein aggregation and (2) to extend the amylin-analogs half-life
Why one needs an empty stomach and the other doesnt Semaglutide is a peptide
Hansen LS, Sparre-Ulrich AH, Christensen M, et al
If were going to use these drugs in adolescence, theres got to be an organized attempt to really follow the long-term effects. Trials and Evidence Evidence in children is not as robust as in adults, but a few clinical trials in younger age groups have tested GLP-1 drugs in combination with lifestyle modification counseling programs that included exercise and healthy eating
LDL apheresis should be considered in patients with high Lp(a) concentration and signs of rapid progression of atherosclerosis